{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:32:46Z","timestamp":1793795566661,"version":"4.6.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.hpb.2019.02.013","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T09:36:11Z","timestamp":1553247371000},"page":"1371-1375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program"],"prefix":"10.1016","volume":"21","author":[{"given":"Hans F.A.","family":"Vasen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Boekestijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaura S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akin","family":"Inderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert A.","family":"Bonsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter H.","family":"de Vos tot Nederveen Cappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Feshtali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin N.","family":"Wasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2019.02.013_bib1","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/bjs.4127","article-title":"Familial pancreatic cancer","volume":"90","author":"Bartsch","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2019.02.013_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/gim.2014.153","article-title":"BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study","volume":"17","author":"Zhen","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.hpb.2019.02.013_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1158\/2159-8290.CD-15-0402","article-title":"Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer","volume":"6","author":"Roberts","year":"2016","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hpb.2019.02.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10689-017-0066-y","article-title":"The importance of a well-structured pancreatic screening program for familial and hereditary pancreatic cancer","volume":"17","author":"Vasen","year":"2018","journal-title":"Fam Cancer"},{"key":"10.1016\/j.hpb.2019.02.013_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/gutjnl-2012-303108","article-title":"International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer","volume":"62","author":"Canto","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2019.02.013_bib6","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1200\/JCO.2015.64.0730","article-title":"Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three european expert centers","volume":"34","author":"Vasen","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2019.02.013_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.gastro.2010.11.048","article-title":"Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation","volume":"140","author":"Vasen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2019.02.013_bib8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/MPA.0000000000000587","article-title":"Early pancreatic ductal adenocarcinoma survival is dependent on size: positive implications for future targeted screening","volume":"45","author":"Hur","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2019.02.013_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00006676-200403000-00007","article-title":"Onset symptoms and tumor locations as prognostic factors of pancreatic cancer","volume":"28","author":"Watanabe","year":"2004","journal-title":"Pancreas"},{"key":"10.1016\/j.hpb.2019.02.013_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/13651820802291233","article-title":"The anatomic location of pancreatic cancer is a prognostic factor for survival","volume":"10","author":"Artinyan","year":"2008","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2019.02.013_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcu.1870110105","article-title":"Pancreatic duct diameter: sonographic measurement in normal subjects","volume":"11","author":"Hadidi","year":"1983","journal-title":"J\u00a0Clin Ultrasound"},{"key":"10.1016\/j.hpb.2019.02.013_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/rg.263055164","article-title":"Multimodality imaging of pancreatic and biliary congenital anomalies","volume":"26","author":"Mortel\u00e9","year":"2006","journal-title":"Radiographics"},{"key":"10.1016\/j.hpb.2019.02.013_bib13","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.hpb.2019.02.013_bib14","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2019.02.013_bib15","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2019.02.013_bib16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2018.05.035","article-title":"Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance","volume":"155","author":"Canto","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2019.02.013_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X1930098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X1930098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:19:56Z","timestamp":1761265196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X1930098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1365182X1930098X"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.02.013","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}